Industry-sponsored cost-effectiveness study of TAVI
- PMID: 22730481
- DOI: 10.1136/heartjnl-2012-302270
Industry-sponsored cost-effectiveness study of TAVI
Comment on
-
Cost-effectiveness of transcatheter aortic valve replacement in patients ineligible for conventional aortic valve replacement.Heart. 2012 Mar;98(5):370-6. doi: 10.1136/heartjnl-2011-300444. Epub 2011 Nov 10. Heart. 2012. PMID: 22076021
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources